ABEONA THERAPEUTICS INC. Sales Revenue, Goods, Net (Deprecated 2018-01-31)
ABEONA THERAPEUTICS INC. (ABEO) reported Sales Revenue, Goods, Net (Deprecated 2018-01-31) of $0 for the 12-month period ending 2014-12-31, per its 10-K filed 2015-03-31.
Discontinued › Expense Statement › Operating Expenses
us-gaap:SalesRevenueGoodsNet · last filed 2015-03-31
- ABEONA THERAPEUTICS INC. sales revenue, goods, net (deprecated 2018-01-31) for the quarter ending 2014-12-31 was $0.00.
- ABEONA THERAPEUTICS INC. sales revenue, goods, net (deprecated 2018-01-31) for the quarter ending 2014-09-30 was $0.00.
- ABEONA THERAPEUTICS INC. sales revenue, goods, net (deprecated 2018-01-31) for the quarter ending 2014-06-30 was $0.00, a 100.00% decline year-over-year.
- ABEONA THERAPEUTICS INC. sales revenue, goods, net (deprecated 2018-01-31) for the quarter ending 2014-03-31 was $0.00, a 100.00% decline year-over-year.
- ABEONA THERAPEUTICS INC. sales revenue, goods, net (deprecated 2018-01-31) for fiscal 2014 was $0.00, a 100.00% decline from fiscal 2013.
- ABEONA THERAPEUTICS INC. sales revenue, goods, net (deprecated 2018-01-31) for fiscal 2013 was $1.53M, a 46.63% decline from fiscal 2012.
- ABEONA THERAPEUTICS INC. sales revenue, goods, net (deprecated 2018-01-31) for fiscal 2012 was $2.87M, a 431.54% increase from fiscal 2011.
- ABEONA THERAPEUTICS INC. sales revenue, goods, net (deprecated 2018-01-31) for fiscal 2011 was $539.00K, a 6637.50% increase from fiscal 2010.
| Period end | Sales Revenue, Goods, Net (Deprecated 2018-01-31) 3 month | Sales Revenue, Goods, Net (Deprecated 2018-01-31) 3 month as first filed | Sales Revenue, Goods, Net (Deprecated 2018-01-31) 6 month | Sales Revenue, Goods, Net (Deprecated 2018-01-31) 6 month as first filed | Sales Revenue, Goods, Net (Deprecated 2018-01-31) 9 month | Sales Revenue, Goods, Net (Deprecated 2018-01-31) 9 month as first filed | Sales Revenue, Goods, Net (Deprecated 2018-01-31) 12 month | Sales Revenue, Goods, Net (Deprecated 2018-01-31) 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2014-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-31 | $0.00 derived: sum of 2 quarters · filed 2015-03-31 | $0.00 derived: sum of 3 quarters · filed 2015-03-31 | $0.00 10-K · filed 2015-03-31 | ||||
| 2014-09-30 | $0.00 10-Q · filed 2014-11-14 | $0.00 derived: sum of 2 quarters · filed 2014-11-14 | $0.00 10-Q · filed 2014-11-14 | -$13.00K derived: sum of 4 quarters · filed 2015-03-31 | ||||
| 2014-06-30 | $0.00 10-Q · filed 2014-08-14 | $0.00 10-Q · filed 2014-08-14 | -$13.00K derived: sum of 3 quarters · filed 2015-03-31 | -$13.00K derived: sum of 4 quarters · filed 2015-03-31 | ||||
| 2014-03-31 | $0.00 10-Q · filed 2014-05-12 | -$13.00K derived: sum of 2 quarters · filed 2015-03-31 | -$13.00K derived: sum of 3 quarters · filed 2015-03-31 | $367.00K derived: sum of 4 quarters · filed 2015-03-31 | ||||
| 2013-12-31 | -$13.00K derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-31 | -$13.00K derived: sum of 2 quarters · filed 2015-03-31 | $367.00K derived: sum of 3 quarters · filed 2015-03-31 | $1.53M 10-K · filed 2015-03-31 | ||||
| 2013-09-30 | $0.00 10-Q · filed 2014-11-14 | $380.00K derived: sum of 2 quarters · filed 2014-11-14 | $1.54M 10-Q · filed 2014-11-14 | $2.46M derived: sum of 4 quarters · filed 2014-11-14 | ||||
| 2013-06-30 | $380.00K 10-Q · filed 2014-08-14 | $1.54M 10-Q · filed 2014-08-14 | $2.46M derived: sum of 3 quarters · filed 2014-08-14 | $3.24M derived: sum of 4 quarters · filed 2014-08-14 | ||||
| 2013-03-31 | $1.16M 10-Q · filed 2014-05-12 | $2.08M derived: sum of 2 quarters · filed 2014-05-12 | $2.86M derived: sum of 3 quarters · filed 2014-05-12 | $3.47M derived: sum of 4 quarters · filed 2014-05-12 | ||||
| 2012-12-31 | $915.00K derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-26 | $1.70M derived: sum of 2 quarters · filed 2014-03-26 | $2.31M derived: sum of 3 quarters · filed 2014-03-26 | $2.87M 10-K · filed 2014-03-26 | ||||
| 2012-09-30 | $781.00K 10-Q · filed 2013-11-14 | $1.40M derived: sum of 2 quarters · filed 2013-11-14 | $1.95M 10-Q · filed 2013-11-14 | $2.35M derived: sum of 4 quarters · filed 2013-11-14 | ||||
| 2012-06-30 | $615.00K 10-Q · filed 2013-08-14 | $1.17M 10-Q · filed 2013-08-14 | $1.57M derived: sum of 3 quarters · filed 2013-08-14 | $1.65M derived: sum of 4 quarters · filed 2013-08-14 | ||||
| 2012-03-31 | $554.00K 10-Q · filed 2013-05-15 | $572.00K 10-Q · filed 2012-05-15 | $956.00K derived: sum of 2 quarters · filed 2013-05-15 | $1.04M derived: sum of 3 quarters · filed 2013-05-15 | $1.08M derived: sum of 4 quarters · filed 2013-05-15 | |||
| 2011-12-31 | $402.00K derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-20 | $484.00K derived: sum of 2 quarters · filed 2013-03-20 | $526.00K derived: sum of 3 quarters · filed 2013-03-20 | $539.00K 10-K · filed 2013-03-20 | $548.00K 10-K · filed 2012-03-23 | |||
| 2011-09-30 | $82.00K 10-Q · filed 2012-11-14 | $124.00K derived: sum of 2 quarters · filed 2012-11-14 | $137.00K 10-Q · filed 2012-11-14 | $138.00K 10-Q · filed 2011-11-14 | $145.00K derived: sum of 4 quarters · filed 2012-11-14 | |||
| 2011-06-30 | $43.00K 10-Q · filed 2011-08-15 | $55.00K 10-Q · filed 2012-08-14 | $56.00K 10-Q · filed 2011-08-15 | $63.00K derived: sum of 3 quarters · filed 2012-08-14 | $63.00K derived: sum of 4 quarters · filed 2012-08-14 | |||
| 2011-03-31 | $13.00K 10-Q · filed 2012-05-15 | $21.00K derived: sum of 2 quarters · filed 2012-05-15 | $21.00K derived: sum of 3 quarters · filed 2012-05-15 | $21.00K derived: sum of 4 quarters · filed 2012-05-15 | ||||
| 2010-12-31 | $8.00K derived: 10-K 12 month − 10-Q 9 month · filed 2012-03-23 | $8.00K derived: sum of 2 quarters · filed 2012-03-23 | $8.00K derived: sum of 3 quarters · filed 2012-03-23 | $8.00K 10-K · filed 2012-03-23 | ||||
| 2010-09-30 | $0.00 10-Q · filed 2011-11-14 | $0.00 derived: sum of 2 quarters · filed 2011-11-14 | $0.00 10-Q · filed 2011-11-14 | |||||
| 2010-06-30 | $0.00 10-Q · filed 2011-08-15 | $0.00 10-Q · filed 2011-08-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| GT Biopharma, Inc. (GTBP) | United States | $0.309B | -4.58 |
| Prelude Therapeutics Inc (PRLD) | United States | $0.318B | -7.01 |
| Evommune, Inc. (EVMN) | United States | $0.320B | -5.10 |
| BridgeBio Oncology Therapeutics, Inc. (BBOT) | United States | $0.320B | -3.35 |
| Vanda Pharmaceuticals Inc. (VNDA) | United States | $0.302B | -1.35 |
| STANDARD BIOTOOLS INC. (LAB) | United States | $0.297B | 3.80 |
| ROCKET PHARMACEUTICALS, INC. (RCKT) | United States | $0.296B | -21.78 |
| BioAge Labs, Inc. (BIOA) | United States | $0.333B | -11.88 |
| Fulcrum Therapeutics, Inc. (FULC) | United States | $0.289B | -3.28 |
| Contineum Therapeutics, Inc. (CTNM) | United States | $0.289B | -4.40 |